Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 56 Ovarian Neoplasms 35 Carcinoma, Hepatocellular 35 Neoplasms 25 Fallopian Tube Neoplasms 20 Carcinoma, Non-Small-Cell Lung 19 Endometrial Neoplasms 13 Glioblastoma 11 Breast Neoplasms 11 Brain Neoplasms 11 Neoplasm Metastasis 9 Colonic Neoplasms 9 Lung Neoplasms 8 Uterine Cervical Neoplasms 7 Liver Neoplasms 7 Rectal Neoplasms 6 Glioma 6 Biliary Tract Neoplasms 6 Stomach Neoplasms 5 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Gastrointestinal Neoplasms 4 Digestive System Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Small Cell Lung Carcinoma 3 Sarcoma 3 Recurrence 3 Peritoneal Neoplasms 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Pancreatic Neoplasms 3

Interventions

Magnetic Resonance Spectroscopy 9 Specimen Handling 7 X-Rays 6 Phantoms, Imaging 6 Nuclear Medicine Department, Hospital 5 Temozolomide 4 Biopsy 4 Vincristine 3 Cyclophosphamide 3 Cisplatin 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 selpercatinib 2 pembrolizumab 2 palbociclib 2 olaparib 2 lutetium Lu 177 dotatate 2 larotrectinib 2 ivosidenib 2 erdafitinib 2 ensartinib 2 Radiotherapy 2 Radiation 2 Platinum 2 Lomustine 2 LY3023414 2 Diphtheria-Tetanus Vaccine 2 1,2-diaminocyclohexaneplatinum II citrate 2 sodium thiosulfate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Medulloblastoma × Bevacizumab × 90 days × Clear all

NCT07346157 2026-06-01

PNOC044

University of California, San Francisco

Phase 1/2 Not yet recruiting

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡